ClinicalTrials.gg
RecruitingNCT07575048Updated May 8, 2026

Assertiveness Training for Communication Skills

An interventional study of Assertiveness Skills Training in Communication, sponsored by Amasya University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-08.

Sponsored by Amasya University · Not applicable, Interventional, and Other

From the registry’s dates

  • Started Mar 2026; still recruiting 7 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This study aims to determine the effect of virtual reality-based assertiveness training on strengthening the communication skills of oncology nurses.

Read the detailed description

Introduction: Oncology nurses, who provide professional care to patients and their families during the cancer process, need to possess strong communication skills.

Aim: This research is planned to strengthen the communication skills of oncology nurses through virtual reality-based assertiveness training.

Method: The research will be conducted in the oncology unit of a university hospital using a randomized controlled experimental design. Data will be collected using a Sociodemographic Data Form, the Voltan-Acar Self-Determination Scale, the Maslach Burnout Inventory, the Emotion Expression Scale, and the Assertiveness Skills Form. Data collection forms will be administered before the start of the intervention and after the completion of the virtual reality-based assertiveness training. The assertiveness skills training group will receive 8 weeks of training content, once a week for 30-40 minutes, in a group training format.

02

Conditions studied

  • Communication

Browse trials for

Keywords

  • Education
03

In context

Communication

719 studies on the registry are indexed under Communication; 159 are open to participants now.

This study's planned enrollment of 60 is below the median of 144 across 571 interventional studies indexed under Communication.

Browse Communication studies →

Lead sponsor

Amasya University is the lead sponsor of 81 studies on the registry; 23 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Those who agree to participate in the study,
  • Those who are 18 years of age or older,
  • Those who have been working in oncology clinics for at least 6 months.

Exclusion criteria

Exclusion Criteria:

  • Those who gave incomplete answers to the scales used in the study,
  • Those who have previously participated in assertiveness skills training.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Assertiveness Skills Training

    The content of the Assertiveness Training is based on the assertiveness training developed by Michel and Fursland (2008). Session 1: Introduction, Welcome and Orientation, The Concept of Assertiveness; Session 2: Types of Behavior; Session 3: Assertiveness Techniques; Session 4: Dealing with Criticism; Session 5: Saying "No"; Session 6: Disappointment; Session 7: Relaxation Exercises; Session 8: Application, General Discussions and Evaluation. First, scenario-based videos will be created to develop assertiveness training skills, and these videos will be integrated into virtual reality glasses. Two videos will be created for each scenario. The first video will address a communication problem experienced by the nurse. The second video will be educational content using effective communication skills in the problem experienced by the nurse. Virtual reality applications will be conducted individually with each nurse.

    Other: Assertiveness Skills Training

  • No intervention
    Control

    Control group: Nurses in the control group will not receive assertiveness skills training; they will only complete data collection forms during two designated time periods.

Interventions

  • OtherAssertiveness Skills Training

    The content of the Assertiveness Training is based on the assertiveness training developed by Michel and Fursland (2008). Session 1: Introduction, Welcome and Orientation, The Concept of Assertiveness; Session 2: Types of Behavior; Session 3: Assertiveness Techniques; Session 4: Dealing with Criticism; Session 5: Saying "No"; Session 6: Disappointment; Session 7: Relaxation Exercises; Session 8: Application, General Discussions and Evaluation. First, scenario-based videos will be created to develop assertiveness training skills, and these videos will be integrated into virtual reality glasses. Two videos will be created for each scenario. The first video will address a communication problem experienced by the nurse. The second video will be educational content using effective communication skills in the problem experienced by the nurse. Virtual reality applications will be conducted individually with each nurse.

06

What researchers measure

Primary outcomes

  1. Voltan-Acar Self-Determination Scale

    This scale was developed by Voltan Acar and Öğretmen (2007) to measure individuals' assertiveness levels. The scale contains a total of 28 items: 17 for the shyness dimension and 11 for the assertiveness dimension. It is a six-point Likert scale. The lowest possible score is 28, and the highest is 168. As an individual's score on the scale increases, their level of assertiveness increases.

    Time frame: 8 week

  2. Maslach Burnout Inventory

    The scale was developed by Maslach and Jackson (1981) and adapted into Turkish by Ergin (1993), the Turkish version of this inventory contains 22 items and uses a 5-point Likert scale with values ranging from 0 to 4. It has three sub-dimensions: emotional exhaustion, depersonalization, and personal accomplishment. Higher scores indicate increased burnout.

    Time frame: 8 week

  3. Expression of Emotions Scale

    The scale was developed by King and Emmons (1990) and adapted into Turkish by Kuzucu (2011), this 16-item Likert-type rating scale consists of three sub-dimensions: positive, negative, and closeness. High scores on the scale indicate a high tendency to express emotions.

    Time frame: 8 week

07

Study locations

1 of 1 sites recruiting
  • AmasyaU
    Amasya, Turkey (Türkiye)
    Recruiting
    • Neşe Uysal · Contact
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2026 (actual). Primary completion is estimated for Nov 2026, 7 months after the start.

Of 390 non-industry interventional studies with no phase under Communication, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 36. This study's planned 7 months is below that.

Counting every sponsor, half of 394 studies reached it within 18 months; a quarter within 6 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
May 3, 2026
First posted
May 8, 2026
StartActual
Mar 30, 2026
Primary completionEst.
Nov 15, 2026
CompletionEst.
Dec 15, 2026
Last update
May 8, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07575048
Lead sponsor
Amasya University
Responsible party
Sponsor
First posted
May 8, 2026
Start date
Mar 30, 2026
Primary completion
Nov 15, 2026 (estimated)
Completion
Dec 15, 2026 (estimated)
Last update
May 8, 2026

Study contacts

Neşe Uysal
Contact
nese.uysal@amasya.edu.tr
(90)3582181767
Neşe Uysal
principal investigator · Amasya University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion